| Name | Title | Contact Details |
|---|
MedAmerica is one of the leading healthcare practice management organizations in the United States. Since 1975, we have successfully managed hospital-based physician group practices across the Acute Care Continuum, with expertise in emergency medicine, hospital medicine, ambulatory & urgent care, and other acute care specialties. We provide the strategy, solutions, and systems to help our clients successfully navigate today’s complex healthcare landscape. MedAmerica offers a full range of cost-effective practice management solutions. We’re in the business of enabling physician groups, hospitals, and other healthcare organizations to be more efficient, productive, and profitable – all while providing higher quality care and improved outcomes.
Xperiome is a global healthtech company that helps pharma get to know rare disease patients and their conditions faster by delivering deep insights into the patient experience. We have created Raremark as the place for the lived experience of rare disease. Raremark supports every stage of a patient`s health odyssey: a community to crowdsource wisdom, a library to catalog the lived experience, and a matching engine to find research opportunities. This data-driven knowledge bank of the rare experience allows us to match research-ready members to clinical and real-world studies, faster and smarter than ever before.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
American Society of Breast Disease is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
RealAge, Inc. is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.